Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment

E. Radwanska, R. G. Rawlins, I. Tummon, V. Maclin, Z. Binor, W. P. Dmowski

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A patient with PCO and primary infertility had undergone numerous failed attempts of ovulation induction. She then was treated with GnRHa leuprolide 500 μg subcutaneously daily for 4 weeks, later combined with hMG 225 IU IM daily for 8 days and hCG IU IM. Six oocytes were retrieved for IVF, four fertilized and two were replaced. Twin pregnancy was established and delivered at term. Hyperstimulation syndrome was managed conservatively.

Original languageEnglish (US)
Pages (from-to)356-359
Number of pages4
JournalFertility and Sterility
Volume49
Issue number2
DOIs
StatePublished - Jan 1 1988

Fingerprint

Ovarian Diseases
Leuprolide
Twin Pregnancy
Ovulation Induction
Fertilization in Vitro
Gonadotropin-Releasing Hormone
Infertility
Oocytes
Therapeutics

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment. / Radwanska, E.; Rawlins, R. G.; Tummon, I.; Maclin, V.; Binor, Z.; Dmowski, W. P.

In: Fertility and Sterility, Vol. 49, No. 2, 01.01.1988, p. 356-359.

Research output: Contribution to journalArticle

@article{ac396596290247d2880a37e8a71c3880,
title = "Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment",
abstract = "A patient with PCO and primary infertility had undergone numerous failed attempts of ovulation induction. She then was treated with GnRHa leuprolide 500 μg subcutaneously daily for 4 weeks, later combined with hMG 225 IU IM daily for 8 days and hCG IU IM. Six oocytes were retrieved for IVF, four fertilized and two were replaced. Twin pregnancy was established and delivered at term. Hyperstimulation syndrome was managed conservatively.",
author = "E. Radwanska and Rawlins, {R. G.} and I. Tummon and V. Maclin and Z. Binor and Dmowski, {W. P.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/S0015-0282(16)59728-3",
language = "English (US)",
volume = "49",
pages = "356--359",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment

AU - Radwanska, E.

AU - Rawlins, R. G.

AU - Tummon, I.

AU - Maclin, V.

AU - Binor, Z.

AU - Dmowski, W. P.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - A patient with PCO and primary infertility had undergone numerous failed attempts of ovulation induction. She then was treated with GnRHa leuprolide 500 μg subcutaneously daily for 4 weeks, later combined with hMG 225 IU IM daily for 8 days and hCG IU IM. Six oocytes were retrieved for IVF, four fertilized and two were replaced. Twin pregnancy was established and delivered at term. Hyperstimulation syndrome was managed conservatively.

AB - A patient with PCO and primary infertility had undergone numerous failed attempts of ovulation induction. She then was treated with GnRHa leuprolide 500 μg subcutaneously daily for 4 weeks, later combined with hMG 225 IU IM daily for 8 days and hCG IU IM. Six oocytes were retrieved for IVF, four fertilized and two were replaced. Twin pregnancy was established and delivered at term. Hyperstimulation syndrome was managed conservatively.

UR - http://www.scopus.com/inward/record.url?scp=0023845741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023845741&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(16)59728-3

DO - 10.1016/S0015-0282(16)59728-3

M3 - Article

C2 - 3123281

AN - SCOPUS:0023845741

VL - 49

SP - 356

EP - 359

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -